State Street Corp. Maintains Passive Stake in Organon & Co.
Ticker: OGN · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1821825
| Field | Detail |
|---|---|
| Company | Organon & CO. (OGN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, pharmaceuticals
TL;DR
**State Street Corp. still holds Organon stock, signaling passive institutional confidence.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Organon & Co. common stock as of December 31, 2023. This filing updates their previous disclosure, confirming their continued significant, but passive, stake in the pharmaceutical company. For investors, this means a large institutional holder remains invested, which can signal confidence, but it's a passive stake, so no activist moves are expected.
Why It Matters
This filing confirms a major institutional investor, State Street Corporation, continues to hold a significant, passive stake in Organon & Co., which can be a positive signal of institutional confidence for current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing is routine and indicates a passive investment, posing minimal direct risk to Organon & Co. shareholders.
Analyst Insight
An investor should note that a large, passive institutional holder like State Street Corporation maintains its position, suggesting stability rather than any impending major corporate action or activist pressure. This filing doesn't provide new information on share count or percentage, but confirms continued institutional presence.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Organon & Co. (company) — the subject company whose securities are being reported
- 04-2456637 (number) — State Street Corporation's IRS Identification Number
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
FAQ
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, which is filed by institutional investors who acquire beneficial ownership of more than 5% of a company's stock but do not intend to influence or control the company. The 'A' indicates it's an amendment to a previously filed statement, updating information as of December 31, 2023.
Who is the reporting person in this filing?
The reporting person is State Street Corporation, a financial institution with IRS Identification No. 04-2456637, based in Boston, Massachusetts.
Which company's stock is the subject of this filing?
The subject company is Organon & Co., a pharmaceutical preparations company with CIK 0001821825, whose common stock is identified by CUSIP number 68622V106.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as stated on the cover page of the filing.
Under which SEC rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1(B), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding Organon & Co. (OGN).